{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:45:13Z","timestamp":1791859513151,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ctrv.2026.103219","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:41:41Z","timestamp":1790869301000},"page":"103219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The prognostic value of pathological response in soft tissue sarcoma: A systematic review"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3606-8544","authenticated-orcid":false,"given":"Bauke H.G.","family":"van Riet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6580-7257","authenticated-orcid":false,"given":"Stijn J.C.","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van der Klaauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2989-2279","authenticated-orcid":false,"given":"Neeltje","family":"Steeghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1155-0481","authenticated-orcid":false,"given":"Judith V.G.M.","family":"Bov\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3483-4241","authenticated-orcid":false,"given":"Astrid N.","family":"Scholten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7549-3338","authenticated-orcid":false,"given":"Winette T.A.","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4834-4331","authenticated-orcid":false,"given":"Rick L.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1086-8108","authenticated-orcid":false,"given":"Petur","family":"Snaebjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2303-3468","authenticated-orcid":false,"given":"Winan J.","family":"van Houdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctrv.2026.103219_bb0005","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijrobp.2012.01.062","article-title":"Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?","volume":"84","author":"Haas","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.ctrv.2026.103219_bb0010","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2026.103219_bb0015","doi-asserted-by":"crossref","unstructured":"Blay JY, Le Cesne A, Penel N et al. The nationwide cohort of 26,883 patients with sarcomas treated in NETSARC reference network between 2010 and 2015 in France: major impact of multidisciplinary board presentation prior to 1st treatment. Ann Oncol 2016; 27: vi483.","DOI":"10.1093\/annonc\/mdw388.03"},{"key":"10.1016\/j.ctrv.2026.103219_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102820","article-title":"Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: a systematic review","volume":"130","author":"Boulouta","year":"2024","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103219_bb0025","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis","volume":"26","author":"Spring","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103219_bb0030","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/annonc\/mdr491","article-title":"Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European osteosarcoma intergroup randomised controlled trials","volume":"23","author":"Whelan","year":"2012","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103219_bb0035","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.eururo.2013.06.049","article-title":"Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis","volume":"65","author":"Petrelli","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2026.103219_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2015.09.021","article-title":"Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European organization for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC-STBSG) recommendations for pathological examination and reporting","volume":"53","author":"Wardelmann","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2026.103219_bb0045","unstructured":"Dei Tos AP, Agaimy A, Bov\u00e9e JVMG et al. Soft tissue sarcoma histopathology reporting guide \u2013 Resection specimens. 1st edition. International collaboration on Cancer reporting; Sydney, Australia. ISBN: 978-1-922324-19-1. 2021."},{"issue":"13","key":"10.1016\/j.ctrv.2026.103219_bb0050","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1200\/JCO.2001.19.13.3203","article-title":"Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas","volume":"19","author":"Eilber","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2026.103219_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2018.05.007","article-title":"Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: a systematic review and meta-analysis","volume":"69","author":"Salah","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103219_bb0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1530\/EOR-2025-0198","article-title":"Necrosis following neoadjuvant radiotherapy and its association with oncological outcome in soft tissue sarcoma patients: a systematic literature review and meta-analysis","volume":"11","author":"Smolle","year":"2026","journal-title":"EFORT Open Rev"},{"key":"10.1016\/j.ctrv.2026.103219_bb0065","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103219_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103219_bb0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.ctrv.2026.103219_bb0080","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ctrv.2026.103219_bb0085","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ctrv.2026.103219_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8029157","article-title":"Myxoid liposarcoma: treatment outcomes from chemotherapy and radiation therapy","volume":"2018","author":"Chowdhry","year":"2018","journal-title":"Sarcoma"},{"key":"10.1016\/j.ctrv.2026.103219_bb0095","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1200\/CCI.21.00062","article-title":"Implementing a machine learning strategy to predict pathologic response in patients with soft tissue sarcomas treated with neoadjuvant chemotherapy","volume":"5","author":"Cromb\u00e9","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103219_bb0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjc.2014.635","article-title":"Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma","volume":"112","author":"Andreou","year":"2015","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.ctrv.2026.103219_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.40177","article-title":"Histopathological response after neoadjuvant chemotherapy for high-risk soft-tissue sarcomas: a secondary analysis of a randomized clinical trial","volume":"8","author":"Pasquali","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103219_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-024-12027-w","article-title":"The effect of chemo- and radiotherapy on tumor necrosis in soft tissue sarcoma\u2013 does it influence prognosis?","volume":"24","author":"Fromm","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctrv.2026.103219_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jor.2025.01.030","article-title":"Rethinking tumor viability as prognostic factor in soft tissue sarcoma","volume":"68","author":"Montreuil","year":"2025","journal-title":"J Orthop"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103219_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-09195-y","article-title":"Standardization of evaluation method and prognostic significance of histological response to preoperative chemotherapy in high-grade non-round cell soft tissue sarcomas","volume":"22","author":"Oda","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctrv.2026.103219_bb0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.blo.0000238864.69486.59","article-title":"Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma","volume":"455","author":"Menendez","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ctrv.2026.103219_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-11-510","article-title":"A phase II study evaluating neo\u2212\/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma","volume":"11","author":"Schmitt","year":"2011","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103219_bb0135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12957-018-1462-y","article-title":"Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan clinical oncology group study JCOG0304","volume":"16","author":"Tanaka","year":"2018","journal-title":"World J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103219_bb0140","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ejso.2021.02.024","article-title":"Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: results of a retrospective multicenter study","volume":"47","author":"Bonvalot","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103219_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-52619-5_92-1","article-title":"Effect of favorable pathologic response after neoadjuvant radiation therapy alone in soft-tissue sarcoma","volume":"8","author":"Palm","year":"2023","journal-title":"Adv Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103219_bb0150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jamaoncol.2023.0042","article-title":"Pathologic complete response and clinical outcomes in patients with localized soft tissue sarcoma treated with neoadjuvant chemoradiotherapy or radiotherapy: the NRG\/RTOG 9514 and 0630 nonrandomized clinical trials","volume":"9","author":"Wang","year":"2023","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103219_bb0155","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1016\/j.prro.2024.10.008","article-title":"Comparison of pathologic tumor necrosis of conventional versus ultrahypofractionated preoperative radiation therapy in localized extremity soft tissue sarcoma and its correlation with clinical outcomes","volume":"15","author":"Hanafi","year":"2025","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103219_bb0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijrobp.2017.02.087","article-title":"Histologic appearance after preoperative radiation therapy for soft tissue sarcoma: assessment of the european organization for research and treatment of cancer-soft tissue and bone sarcoma group response score","volume":"98","author":"Schaefer","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103219_bb0165","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/PAS.0000000000001922","article-title":"Neoadjuvant radiation in high-grade soft-tissue sarcomas: histopathologic features and response evaluation","volume":"46","author":"Boxberg","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"21","key":"10.1016\/j.ctrv.2026.103219_bb0170","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1002\/cncr.34945","article-title":"Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall","volume":"129","author":"Danieli","year":"2023","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103219_bb0175","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/PAS.0000000000001214","article-title":"Histologic response to neoadjuvant therapy is not predictive of favorable outcomes in high-grade pleomorphic soft tissue sarcoma","volume":"43","author":"Cates","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103219_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/0284186X.2023.2166427","article-title":"Correlation of radiological and histopathological response after neoadjuvant radiotherapy in soft tissue sarcoma","volume":"62","author":"Reijers","year":"2023","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103219_bb0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cam4.4428","article-title":"Extent of tumor fibrosis\/hyalinization and infarction following neoadjuvant radiation therapy is associated with improved survival in patients with soft-tissue sarcoma","volume":"11","author":"Rao","year":"2022","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103219_bb0190","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00432-019-02885-4","article-title":"Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma","volume":"145","author":"Gannon","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103219_bb0195","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jso.23775","article-title":"Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma","volume":"111","author":"Vaynrub","year":"2015","journal-title":"J Surg Oncol"},{"issue":"16","key":"10.1016\/j.ctrv.2026.103219_bb0200","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1002\/cncr.25271","article-title":"Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram","volume":"116","author":"Donahue","year":"2010","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103219_bb0205","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/COC.0000000000000443","article-title":"Long-term outcomes with ifosfamide-based hypofractionated preoperative chemoradiotherapy for extremity soft tissue sarcomas","volume":"41","author":"Pennington","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"23","key":"10.1016\/j.ctrv.2026.103219_bb0210","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1002\/cncr.28945","article-title":"Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy","volume":"120","author":"Mullen","year":"2014","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103219_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051074","article-title":"Pathologic response rates after neoadjuvant therapy for sarcoma: a single institution study","volume":"13","author":"Seldon","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103219_bb0220","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1245\/s10434-018-6346-4","article-title":"Epirubicin and ifosfamide with preoperative radiation for high-risk soft tissue sarcomas","volume":"25","author":"Lu","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103219_bb0225","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.ejso.2018.05.011","article-title":"Histopathological tumor response following neoadjuvant hyperthermic isolated limb perfusion in extremity soft tissue sarcomas: evaluation of the EORTC-STBSG response score","volume":"44","author":"Stevenson","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"10.1016\/j.ctrv.2026.103219_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16203449","article-title":"What is the prognostic value of the pathologic response after neoadjuvant radiotherapy in soft tissue sarcoma? An institutional study using the EORTC-STBSG response score","volume":"16","author":"Stergioula","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103219_bb0235","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/CORR.0000000000002380","article-title":"Ninety percent or greater tumor necrosis is associated with survival and social determinants of health in patients with osteosarcoma in the national cancer database","volume":"481","author":"Richardson","year":"2023","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103219_bb0240","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00428-023-03615-5","article-title":"Histological response to radiotherapy is an early event in myxoid liposarcoma","volume":"483","author":"Lam","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ctrv.2026.103219_bb0245","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejca.2017.06.032","article-title":"A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: personalised sarcoma care (PERSARC)","volume":"83","author":"van Praag","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2026.103219_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.11.008","article-title":"Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors","volume":"17","author":"Callegaro","year":"2019","journal-title":"eClinicalMedicine"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103219_bb0255","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1470-2045(26)00067-7","article-title":"Bayesian sequential learning for prognostication in extremity soft tissue sarcoma (BayeSarc): a retrospective, multicentre cohort study","volume":"27","author":"Callegaro","year":"2026","journal-title":"Lancet Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:48:04Z","timestamp":1791856084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737226001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":51,"alternative-id":["S0305737226001337"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103219","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of pathological response in soft tissue sarcoma: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103219"}}